CollPlant Biotechnologies Files September 2024 6-K Report
Ticker: CLGN · Form: 6-K · Filed: Sep 25, 2024 · CIK: 1631487
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer
TL;DR
CollPlant Biotechnologies filed its September 2024 6-K, updating investors on its foreign private issuer status.
AI Summary
CollPlant Biotechnologies Ltd. filed a Form 6-K on September 25, 2024, to report on its activities for the month of September 2024. The filing is a report of a foreign private issuer and is incorporated by reference into the company's registration statements on Form S-8. The company is based in Rehovot, Israel, and its principal executive office is located at 4 Oppenheimer St, Weizmann Science Park.
Why It Matters
This filing provides an update on CollPlant's ongoing activities as a foreign private issuer, which is important for investors tracking the company's regulatory disclosures and operational status.
Risk Assessment
Risk Level: low — This filing is a routine report of a foreign private issuer and does not contain significant new financial or strategic information that would immediately impact risk.
Key Players & Entities
- CollPlant Biotechnologies Ltd. (company) — Registrant
- 4 Oppenheimer St, Weizmann Science Park (location) — Principal executive office address
- Rehovot, Israel (location) — Company location
- September 2024 (date) — Reporting period
- Form 6-K (document) — Filing type
- Form S-8 (document) — Incorporated registration statement
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is a Report of Foreign Private Issuer filed by CollPlant Biotechnologies Ltd. for the month of September 2024, to update the SEC on its activities.
When was this filing submitted?
The filing was submitted on September 25, 2024.
Where is CollPlant Biotechnologies Ltd. headquartered?
CollPlant Biotechnologies Ltd. is headquartered in Rehovot, Israel, with its principal executive office at 4 Oppenheimer St, Weizmann Science Park.
What other SEC filings are referenced in this document?
This Form 6-K is incorporated by reference into the registrant's Registration Statements on Form S-8 (File No. 3).
Does CollPlant file annual reports under Form 20-F or 40-F?
CollPlant Biotechnologies Ltd. indicates that it files annual reports under cover of Form 20-F.
Filing Stats: 305 words · 1 min read · ~1 pages · Grade level 13.1 · Accepted 2024-09-25 07:00:08
Filing Documents
- ea0215612-6k_collplant.htm (6-K) — 10KB
- 0001213900-24-081550.txt ( ) — 11KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. COLLPLANT BIOTECHNOLOGIES LTD. Date: September 25, 2024 By: /s/ Eran Rotem Name: Eran Rotem Title: Deputy CEO and Chief Financial Officer 2